Statement attributable to:
Barbara McAneny, M.D.
President, American Medical Association
“The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward. Patients and their physicians want to be armed with more information, yet the current situation is opaque if not impenetrable. The committee is rightfully determined to expose factors that lead to high drug prices, and we look forward to continuing our efforts in that regard.”
Media Contact:
About the American Medical Association
The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care. The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.
